1. Home
  2. RGEN vs ALB Comparison

RGEN vs ALB Comparison

Compare RGEN & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ALB
  • Stock Information
  • Founded
  • RGEN 1981
  • ALB 1994
  • Country
  • RGEN United States
  • ALB United States
  • Employees
  • RGEN N/A
  • ALB N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ALB Major Chemicals
  • Sector
  • RGEN Health Care
  • ALB Industrials
  • Exchange
  • RGEN Nasdaq
  • ALB Nasdaq
  • Market Cap
  • RGEN 8.2B
  • ALB 9.6B
  • IPO Year
  • RGEN N/A
  • ALB 1994
  • Fundamental
  • Price
  • RGEN $143.40
  • ALB $89.29
  • Analyst Decision
  • RGEN Buy
  • ALB Hold
  • Analyst Count
  • RGEN 10
  • ALB 23
  • Target Price
  • RGEN $188.38
  • ALB $117.18
  • AVG Volume (30 Days)
  • RGEN 920.4K
  • ALB 2.8M
  • Earning Date
  • RGEN 10-29-2024
  • ALB 10-30-2024
  • Dividend Yield
  • RGEN N/A
  • ALB 1.81%
  • EPS Growth
  • RGEN N/A
  • ALB N/A
  • EPS
  • RGEN N/A
  • ALB N/A
  • Revenue
  • RGEN $602,354,000.00
  • ALB $7,457,882,000.00
  • Revenue This Year
  • RGEN $0.08
  • ALB N/A
  • Revenue Next Year
  • RGEN $12.97
  • ALB $11.65
  • P/E Ratio
  • RGEN N/A
  • ALB N/A
  • Revenue Growth
  • RGEN N/A
  • ALB N/A
  • 52 Week Low
  • RGEN $110.45
  • ALB $71.97
  • 52 Week High
  • RGEN $211.13
  • ALB $188.47
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.56
  • ALB 54.93
  • Support Level
  • RGEN $139.41
  • ALB $75.44
  • Resistance Level
  • RGEN $150.72
  • ALB $94.69
  • Average True Range (ATR)
  • RGEN 5.27
  • ALB 3.90
  • MACD
  • RGEN -0.93
  • ALB 0.05
  • Stochastic Oscillator
  • RGEN 28.36
  • ALB 72.06

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About ALB Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.

Share on Social Networks: